Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 129

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 129
---
         - |     |          |    - |     |                                              |   - |     |                           | - |
| Outstanding at September 30, 2024                 |     |                     | 7,020,000 |     |          | 0.18 |     |                                              | 6.3 |     |                           | - |
| Vested and expected to vest at September 30, 2024 |     |                     | 5,782,500 |     |          | 0.22 |     |                                              | 6.1 |     |                           | - |
| Exercisable at September 30, 2024                 |     |                     | 5,782,500 |     |          | 0.22 |     |                                              | 6.1 |     |                           | - |

<div align='center'>F-23</div>

REVIUM RX.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

U.S. dollars in thousands, except share and per share data

NOTE 10 – TAXES ON INCOME

As of September 30, 2024, July 23, 2024, December 31, 2023, and 2022, the Company’s deferred taxes were in respect of the following:

|                                                |     |     Successor |      |   |     | Predecessor |      |   |     |              |      |   |     |      |      |   |
|                                                |     |     Unaudited |      |   |     |     Audited |      |   |     |              |      |   |     |      |      |   |
|                                                |     | September 30, |      |   |     |    July 23, |      |   |     | December 31, |      |   |     |      |      |   |
|                                                |     |          2024 |      |   |     |        2024 |      |   |     |         2023 |      |   |     | 2022 |      |   |
| Deferred tax assets:                           |     |               |      |   |     |             |      |   |     |              |      |   |     |      |      |   |
| Operating loss carry forward                   |     |               |  177 |   |     |             |  326 |   |     |